[Joint Project with Korea Venture Business Association: Premium Venture Company Exploration (84)] THEDONEE Co., Ltd. (October 30, 2021, Korea University Newspaper)

2025.09.24

Developing portable potassium ion concentration biosensors... realizing health and happiness for humanity

의료기기 및 의약품을 개발하는 ㈜더도니는 나노, 바이오, 의학, 첨단공학 등을 융합해 휴대용 칼륨이온농도 측정용 바이오센서, 페로토시스 기반 항암약물, 3차원 세포 스페로이드 기반 약물평가 플랫폼 개발을 위해 R&D를 수행하는 연구개발 중심의 벤처기업이다. (사진제공=㈜더도니)

THEDONEE Co., Ltd., a venture company focused on research and development, develops medical devices and pharmaceuticals by integrating nanotechnology, biotechnology, medicine, and advanced engineering. (Photo provided by THEDONEE)

[UNN University News Network reporter Hwang Jeong-il] It is engaged in R&D for portable potassium ion concentration biosensors, ferroptosis-based anti-cancer drugs, and 3D cell spheroid-based drug evaluation platforms.

THEDONEE is accelerating R&D efforts to develop portable potassium ion concentration biosensors, ferroptosis-based anti-cancer drugs, and 3D cell spheroid-based drug evaluation platforms. Experts from various fields are actively securing investment, winning national research projects based on prior research, and conducting collaborative research by leveraging R&D networks.

The 3D cell spheroid-based drug evaluation platform kit is targeted for release in 2022, and the portable potassium ion concentration biosensor aims for a 2023 launch. Particularly, no such portable biosensor capable of continuously monitoring blood potassium ion concentration with a small blood sample anytime and anywhere has been released to date.

Kangwon Lee, CEO of THEDONEE, introduced, “To ensure a high degree of completion for rapid clinical entry, we are building a comprehensive library of anti-cancer drugs. Alongside this, our company is the first in the world to conduct R&D on anti-cancer drugs using the newly defined cell death mechanism 'ferroptosis' since 2012, and the products are nearing launch.”

■ Realizing health and happiness for humanity and future generations
The company name ‘THEDONEE’ stands for ‘The Dawn Of Next-gen Essential Expertise’—symbolizing essential knowledge for future generations. The company is committed to securing excellent technology through continuous R&D and realizing the health and happiness of humanity. This spirit drives creative thinking and challenges to develop excellent technological products.

As an R&D-focused venture, The Doni was recently selected for the Ministry of SMEs and Startups’ Startup Growth Technology Development Project called TIPS. The TIPS program selects startups with excellent technology and high growth potential and supports their global expansion. The Doni received 500 million KRW in R&D funding and up to 100 million KRW in startup commercialization funds from the Ministry.

http://news.unn.net/news/articleView.html?idxno=518227

PREV: Ferroptosis Nanoparticles Selectively Induce Cancer Cell Death (August 24, 2021, Yakup Newspaper)

NEXT: THEDONEE Introduces Portable Potassium Ion Self-Measurement Technology at BIO KOREA 2022 "Easily Measure with a Drop of Blood, Reducing Burden for Kidney Failure Patients!" (May 14, 2022, AVING)

List